Palbociclib is a pyridopyrimidine compound that functions as a selective inhibitor of cyclin-dependent kinases 4 and 6. It is used in pharmaceutical manufacturing as an active pharmaceutical ingredient for anticancer therapy.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 571190-30-2
Palbociclib hydrochloride
pharmaceutical raw material
N-Nitroso Palbociclib 1
nitrosamine impurity standard
Methenamine hippurate
pharmaceutical raw material
Naftopidil
pharmaceutical raw material
Bamethan sulfate
pharmaceutical raw material
O-formylcefamandole
pharmaceutical raw material
Tert-Butyl 4-{6-[(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl}piperazine-1-carboxylate
pharmaceutical intermediate
Tert-Butyl 4-[6-[[6-(1-Butoxyethenyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-yl]amino]-pyridin-3-yl]-piperazine-1-carboxylate
pharmaceutical intermediate
6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrido[2,3-d]pyrimidin-7-one
AHJRHEGDXFFMBM-UHFFFAOYSA-N
CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C